From: Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients
Characteristics | Value (68 patients) |
---|---|
Age (18-70 years old) | Median 47.5 years old |
   ≤ 50 | 44 (65%) |
   > 50 | 24 (35%) |
Co-morbidities (patients) | Â |
   DM and/or Hypertension | 14 (20.6%) |
   No co-morbidities | 54 (79.4%) |
Pre RT otitis media (ears) | Â |
   Yes | 34 (25.4%) |
   No | 71 (53%) |
   No data | 29 (21.6%) |
Post RT otitis media (ears) | Â |
   Yes | 31 (23.1%) |
   No | 93 (69.4%) |
   No data | 10 (7.5%) |
Tumor stage | Â |
   I/II | 15 (22.1%) |
   III/IV | 53 (77.9%) |
Pathology (WHO 2005) | Â |
   WHO type 1 (SCC, keratinized) | 24 (35.2%) |
   WHO type 2 (SCC, non-keratinized) | 4 (5.9%) |
   WHO type 2.2 (Undifferentiated) | 38 (55.9%) |
   Others | 2 (3%) |